glp-1 obesity drugs news today 2025 drug october 21 As interest in medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them. http://www.wtae.com/article/ weight-loss -scam-warning-fueled-by-glp-1-hype-ai-deepfakes GLP-1 Pipeline Update: November 2025

That said, most users cycle it simply because fat loss goals are achieved within 3-4 months, or they want to assess baseline after treatment

Journal of Neuropathology and Experimental Neurology 67, 1055-1062CrossRefGoogle ScholarPubMed 135Ferraiuolo, L., Heath, P.R., Holden, H

Chimploy K, Diaz GD, Li Q, Carter O, Dashwood WM, Mathews CK, Williams DE, Bailey GS, Dashwood RH (2009) E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin

Furthermore, hydroquinone exhibits selective cytotoxicity towards melanocytes, the cells responsible for melanin production, thereby reducing their number and contributing to a more even skin tone

Individuals taking a GLP-1 receptor agonist were 9.1 times more likely to experience pancreatitis, 4.2 times more likely to have a bowel obstruction, and 3.7 times more likely to have gastroparesis compared to patients taking another type of drug